| Künnecke, Kai (EuropaBio 202009 Communciations Officer) |
Public Relations Manager / Investor Relations Manager |
EuropaBio aisbl – the European Association of Bioindustries |
Belgium |
| Küpper, Hans A. (Global Life Science Ventures 199902– Managing Director Munich before Behringwerke) |
Managing Director |
Global Life Science Ventures (Group) |
Germany |
| Küster, Bernhard (Technical Univ Munich 201107 Professor Proteomics + Bioanalytics) |
Professor |
Technical University Munich (TU München, TUM) |
Germany |
| Küster, Sten (Life Science Factory 202207 Program + Event Manager) |
n. a. |
Sartorius (Group) |
Germany |
| Küsthardt, Ulrich (Evonik 201501– Chief Innovation Officer joined Evonik 1997) |
Chief Technology/Technical Officer (CTO) |
Evonik (Group) |
Germany |
| Kähler, Markus (IP Bewertungs AG 200908) |
n. a. |
IP Bewertungs AG (IPB) |
Germany |
| Källblad, Per (Beactica AB 2006– CEO + Co-founder before Medivir AB) |
Chief Executive Officer (CEO) |
Beactica AB |
Sweden |
| Kärtner, Franz (Helmholtz 201603 Head of Research Group at DESY Hamburg + Co-Founder of Cycle GmbH) |
Professor |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Käsmarker, Melanie (Wacker 202204 Managing Director of Wacker Biotech GmbH formerly Scil Proteins) |
Managing Director |
Wacker (Group) |
Germany |
| Kässens, Werner (Kiel (govt) 201202 Prokurist of KiWi GmbH + Managing Director Wissenschaftszentrum Kiel) |
Managing Director |
Kiel (govt city) |
Germany |
| Kääb, Georg (Biocom AG 202109– Managing Editor of |transkript before GoingPublic + BioM) |
Editor / Publisher |
Biocom (Group) |
Germany |
| Köckler, Jochen (Deutsche Messe AG 201410 Member of Management Board) |
Board member, executive |
Deutsche Messe AG |
Germany |
| Köglmayr, Hans-Georg (Leonardo Venture 2007) |
n. a. |
Leonardo Venture GmbH & Co. KGaA |
Germany |
| Köhl, Claudia (Köhl et Feling 201310 Partner) |
Public Relations Manager / Investor Relations Manager |
Innovation Industries (NL) |
Germany |
| Köhler, Christoph (Berlin (govt) 201009 BBges Institute of Toxicology) |
Administrative Officer (personnel) |
Berlin (govt region) |
Germany |
| Köhler, Gert (Creathor GmbH 200601 before Technologieholding) |
n. a. |
Creathor Ventures (Group) |
Germany |
| Köhler, Helmut (Olympus 200412 Managing Director of Olympus Diagnostika GmbH) |
Managing Director |
Olympus (Group) |
Germany |
| Köhler, Jörg (Klocke 201411 Managing Director of IDT Biologika (Riems)) |
Managing Director |
Klocke (Group) |
Germany |
| Köhler, Thomas (AJ RoboScreen 200810 Managing Director) |
Managing Director |
Endress+Hauser (Group) |
Germany |
| Köhn, Heinz Gerhard (Eppendorf 2006 Chief Technology + Production Officer joined in 1999) |
n. a. |
Eppendorf (Group) |
Germany |
| Köhne-Volland, Rudolf (Metronomia Clinical Research GmbH 202001 Managing Director) |
Managing Director |
Metronomia Clinical Research GmbH |
Germany |
| Kölpin, Alexander (WestTech Ventures 201602 COO + Partner) |
Chief Operating Officer (COO) |
WestTech Ventures |
|
| König, Anja (Novartis 200910 Novartis Venture Fund) |
Investment Manager |
Novartis (Group) |
Switzerland |
| König-Wildförster, Corinna (Lonza 201211 Marketing Communications + Product PR Lonza Cologne GmbH) |
public relations / investor relations |
Lonza (Group) |
Germany |
| Köppele, Winni (Laborjournal 200509) |
n. a. |
LJ-Verlag Herfort und Sailer |
Germany |
| Köppen, Herbert (Boehringer Ingelheim Pharma GmbH 200302 Head Cheminformatics) |
n. a. |
Boehringer Ingelheim (Group) |
Germany |
| Köpper, Sabine (PKCie 201305 Managing Partner) |
Managing Partner |
PKCie – Prof. Köpper & Cie Management Consultants GbR |
Germany |
| Körner, Kay (Eppendorf 200610 before artus) |
Product Manager (personnel) |
Eppendorf (Group) |
Germany |
| Köster, Hubert (Caprotec 200805–201009 Managing Director + Univ Hamburg + Sequenom founder + CEO) |
Managing Director |
Caprotec Bioanalytics GmbH |
Germany |
| Köster, Miriam (G. Kisker 200512) |
n. a. |
G. Kisker GbR |
Germany |
| Köstlin, Ulrich (Newron 2013– Board Chairman before until 2011 Management Board Member of Bayer Schering Pharma AG) |
Board member, non-executive |
Newron (Group) |
Italy |
| Kötzner, Lisa (Merck (DE) 202208 Associate Director Business Development + Alliance Management Merck Healthcare) |
Business Development Manager / Strategy Manager |
Merck (DE) (Group) |
Germany |
| La Thangue, Nick (SynOx Therapeutics 202011 CEO) |
Chief Executive Officer (CEO) |
SynOx Therapeutics Ltd. |
Ireland, Republic of |
| Labinger, Barry (Emergent BioSolutions 201408 EVP + President Biosciences Division) |
President/Director/Head Business Group/Unit/Division |
Emergent BioSolutions (Group) |
United States (USA) |
| Labischinski, Harald (Combinature 200504– CEO before 12y Bayer HealthCare) |
Chief Executive Officer (CEO) |
MerLion (Group) |
Germany |
| Laborde, Nadège (Novasep 201311– President of Industrial Biotech business unit joined Novasep 2000) |
President/Director/Head Business Group/Unit/Division |
Novasep (Group) |
France |
| Labrum, Ron (Fenwal 201207 CEO) |
Chief Executive Officer (CEO) |
Fresenius (Group) |
United States (USA) |
| LaCaze, Robert (Bayer 201702–202202 EVP of new Oncology Strategic Business Unit joined 2015 from BMS LEFT 2/22) |
President/Director/Head Business Group/Unit/Division |
Bayer (Group) |
Germany |
| Lacey, Nora (Cell Marque 201410 CEO) |
Chief Executive Officer (CEO) |
Merck (DE) (Group) |
United States (USA) |
| Lachmann, Ingolf (Endress+Hauser 201501 Head RnD at AJ Roboscreen GmbH) |
Research & Development Manager |
Endress+Hauser (Group) |
Germany |
| Lackey, Karen (Evotec 202202 Global Head of Integrated Drug Discovery) |
President/Director/Head Business Group/Unit/Division |
Evotec (Group) |
Germany |
| Lacza, Zsombor (Lacerta Technologies GmbH 201404 CEO + Founder) |
Chief Executive Officer (CEO) |
OrthoSera (Group) |
Austria |
| Ladd, Mark (Helmholtz 201810 Prof + Head of Medical Physics in Radiology at DKFZ) |
Professor |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Ladd, Susanne (Quantum Analysis 201202 Managing Director) |
Managing Director |
Quantum Analysis GmbH (QA) |
Germany |
| Ladestein, Paul (MyCartis 201409– CEO before Biocartis 201404 Managing Director of business unit Evalution + Luminex) |
Chief Executive Officer (CEO) |
MyCartis |
Switzerland |
| Ladiwala, Shiraz (Thermo Fisher 202003 SVP Strategy + Corporate Development joined 20y+ ago TO RETIRE 3/21) |
Corporate Strategy Manager |
Thermo Fisher (Group) |
United States (USA) |
| Lafeuille, Marc (Bayer 201101 Managing Director of Intendis GmbH) |
Managing Director |
Bayer (Group) |
Germany |
| Laffert, Bernd (CCS Cell Culture Service 200805 Head of Research) |
Research & Development Manager |
Evotec (Group) |
Germany |
| Laggner, Peter (Bruker 201201– Director Nanostructure Solutions at Bruker AXS before Hecus X-Ray Systems GmbH) |
President/Director/Head Business Group/Unit/Division |
Bruker (Group) |
Germany |
| Lahn, Michael (iOnctura 201903– CMO before Incyte + AstraZeneca + Lilly) |
Chief Medical Officer (CMO) |
iOnctura (Group) |
Switzerland |
| Lai, Kevin (Singapore (govt) 201203 Deputy Director Biomedical Sciences at EDB) |
n. a. |
Singapore (govt) |
Singapore |
| Laikind, Paul (ViaCyte 201206– CEO before Gensia + Viagen + Metabasis) |
Chief Executive Officer (CEO) |
ViaCyte (Group) |
United States (USA) |
| Lakshman, Vir (KMPG 2017 Partner + Head of Chemicals + Pharma in Germany) |
consulting (economic) |
KPMG (Group) |
Germany |
| Lam, Shim Yok (Eppendorf 201107 Managing Director Eppendorf South & Southeast Asia) |
Managing Director |
Eppendorf (Group) |
Malaysia |
| Lambert, Nicole (Messe München 201404 Trade Fair Marketing Manager) |
Sales Manager / Marketing Manager |
Messe München GmbH |
Germany |
| Lambert, Philip (Centogene 202002– CSO located in Cambrigde MA before Life Biosciences + Charles River + VivoPath) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Centogene (Group) |
Germany |
| Lamkemeyer, Tobias (Univ Cologne 201001 Head Proteomics Core Lab) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
University of Cologne (Universität zu Köln) |
Germany |
| Lammers, Paul (Triumvira Immunologics 202008 CEO) |
Chief Executive Officer (CEO) |
Triumvira Immunologics (Group) |
United States (USA) |
| Lammertz, Marion (Ayoxxa Biosystems 201504 Marketing Manager Communications) |
Sales Manager / Marketing Manager |
Ayoxxa (Group) |
Germany |
| Lamotte, André (HBM BioVentures 200505) |
n. a. |
HBM (Group) |
Switzerland |
| Lamottke, Kai (Bicoll 201308 Managing Director) |
Managing Director |
Bicoll (Group) |
Germany |
| Lampert, Mark (Biotechnology Value Fund 201009 Founder) |
Investment Manager |
BVF Partners L.P. (Biotechnology Venture Fund) |
United States (USA) |
| Lampeter, Eberhard F. (Vita 34 1997–201205 Chairman of Management Board RESIGNED 6/12) |
Chief Executive Officer (CEO) |
Vita 34 (Group) |
Germany |
| Lamraoui, Hamid (UroMems 201611 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
UroMems (FR) |
France |
| Lamzin, Victor |
n. a. |
EMBL (European Molecular Biology Laboratory) |
Germany |
| Lancaster, Madeline (MRC LMB 201908 Principal Researcher + Co-Founder of a:head bio) |
Researcher (university / research institute) |
United Kingdom (GB) (govt) |
United Kingdom (GB) |
| Lanckriet, Heikki (Expedeon 201111 CEO + Founder) |
Chief Executive Officer (CEO) |
2invest (Group) |
United Kingdom (GB) |
| Land, Jörg (Sonormed 201502 Managing Director) |
Managing Director |
Sonormed GmbH |
Germany |
| Lander, Eric (Broad Institute 200607 Director) |
n. a. |
MIT (Massachusetts Institute of Technology) |
United States (USA) |
| Lander, Maik (R-Biopharm 201904– Managing Director Development + Manufacturing at Progen Biotechnik GmbH joined 2016) |
Managing Director |
R-Biopharm (Group) |
Germany |
| Lander, Victoria V. (Vicky) (Bruker 201207–201408 Global Director of Marketing Communciations) |
Sales Manager / Marketing Manager |
Bruker (Group) |
United States (USA) |
| Landich, Rainer (HotSwap 201102 Managing Director HotSwap Lübeck GmbH) |
Managing Director |
HotSwap (Group) |
Germany |
| Landis, Camille A. (T-Knife 202101– CBO + CFO before Unity Biotechnology + Eidos Therapeutics + Relypsa) |
Chief Business Officer (CBO) |
T-Knife (Group) |
Germany |
| Landlinger-Schubert, Christine (PhagoMed 201910c– Director of Lysin Programme before Affiris) |
n. a. |
BioNTech (Group) |
Austria |
| Landry-Lane, Janis (IBM 201304 Director World-wide Deep Computing) |
n. a. |
IBM (Group) |
United States (USA) |
| Landschütze, Volker (aevotis 201011 Managing Director) |
Managing Director |
Advanced Enzyme Technologies (Advanced Enzymes) (Group) |
Germany |
| Landt, Olfert (GenExpress GmbH 201102 Managing Director + TIB Molbiol 200312–2009– Managing Director) |
Managing Director |
TIB Molbiol (Group) |
Germany |
| Landwehr, Jörg (ActeaVentures 201403– Managing Partner before ActeaPartnering + PharmaMar + Roche) |
Managing Director |
ActeaVentures GmbH |
Germany |
| Lanero Fidalgo, Michaël (TreeFrog Therapeutics 202002– COO before Merck KGaA France + GSK Belgium) |
Chief Operating Officer (COO) |
TreeFrog Therapeutics (Group) |
France |
| Lang, Christine (OrganoBalance GmbH –201807 Managing Director + Founder STEPPED DOWN 7/18) |
Managing Director |
Novo Group (Group) |
Germany |
| Lang, Stefan (ImmunoPrecise 202110 CBO formerly Aldevron 201112 Aldevron Freiburg GmbH) |
Chief Business Officer (CBO) |
ImmunoPrecise (Group) |
Canada |
| Lang, Steffen (Novartis 201803 Global Head Technical Operations joined 1994) |
Board member, executive |
Novartis (Group) |
Switzerland |
| Langbehn, Annette (Biocom AG 201405) |
n. a. |
Biocom (Group) |
Germany |
| Langbein, Christian (Prof. Fett & Partner 200809 Ulm) |
n. a. |
Prof. Fett & Partner (Ulm) |
Germany |
| Lange, Bodo M. H. (Alacris Theranostics GmbH 201202 Managing Director) |
Managing Director |
Alacris Theranostics GmbH |
Germany |
| Lange, Christian (Accelero Bioanalytics GmbH 201506 Managing Partner) |
Managing Partner |
Accelero Bioanalytics – Marion Ellermann |
Germany |
| Lange, Dirk T. (Merck (DE) 202202– EVP Global Head of Life Science Services at MilliporeSigma before JSR Corp) |
Chief Executive Officer (CEO) |
MilliporeSigma (business unit of Merck KGaA) |
United States (USA) |
| Lange, Josef (Niedersachsen (govt) 201101 Secretary of State Ministry of Education and Culture) |
Administrative Officer (personnel) |
Niedersachsen (govt region) |
Germany |
| Lange, Sandra (Sachsen (govt) 202208 Public Relations) |
Public Relations Manager / Investor Relations Manager |
Saxony (govt region) |
Germany |
| Lange, Stephan (Boehringer Ingelheim 201908 Head Animal Health for Greater China) |
Regional manager |
Boehringer Ingelheim (Group) |
Germany |
| Langen, Hanno (Roche 200902 GLobal Head Protein Biomarker Technologies Roche Molecular Medicine Laboratories) |
Product Manager (personnel) |
Roche (Group) |
Switzerland |
| Langer, Christof (S-Target Therapeutics 201310 Managing Director + Co-founder) |
Managing Director |
S-Target Therapeutics GmbH |
Austria |
| Langer, Hans J. (EOS Group 1989–201910 CEO + Founder) |
Chief Executive Officer (CEO) |
EOS Group (Electro Optical Systems) (Group) |
Germany |
| Langer, Julian D. (Max Planck 201606 MPI of Biophysics + MPI for Brain Research) |
Researcher (university / research institute) |
Max Planck Society for the Advancement of Science |
Germany |
| Langer, Klaus-Dieter (Grünenthal 201611 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Grünenthal (Group) |
Germany |
| Langer, Ludger (MorphoSys 201312– Head of Clinical Operations + Project Management before PRA International) |
Clinical Research Manager |
MorphoSys (Group) |
Germany |
| Langer, Marie (EOS Group 201910– CEO of EOS GmbH) |
Chief Executive Officer (CEO) |
EOS Group (Electro Optical Systems) (Group) |
Germany |
| Langhärig, Jürgen (Evaxion Biotech 201910– Head of Business Development before Serodus) |
Business Development Manager / Strategy Manager |
Evaxion Biotech A/S (Nasdaq: EVAX) |
Denmark |
| Langner, Klaus-Dieter (Grünenthal 201609 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Grünenthal (Group) |
Germany |
| Langner, Stefan (Bruker 201308 Marketing Communications Manager at Bruker Nano Analytics division) |
Public Relations Manager / Investor Relations Manager |
Bruker (Group) |
|
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 39 40 41 ... 81 82 83 
![Picture [iito] Männer Ballett 650x100px](/banner/iito-business-intelligence-20211013-650-100-summer-banner-series-maenner-ballett.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
